Anteo Diagnostics is a Brisbane-based nano-technology company. Anteo's core technologies and capabilities are in state-of-the-art nanometre-thin ‘coatings’ with custom applications to manage commercially important interactions between different materials.
Anteo owns a growing suite of patented technologies in nanometre-thin ‘primers’, ‘binders’ and ‘coatings’. Anteo’s nanoglue technology is called Mix&Go and caters to healthcare markets.
|
NEW ROLE: Geoffrey Cumming, Managing Director, Chief Executive | 03 Aug 2020 |
|
|
NEW ROLE: Geoffrey Cumming, Non-Executive Director | 03 Aug 2020 |
| Name | Position | Year Started |
|---|---|---|
Non-Executive Director
Managing Director, Chief Executive (2009 to 2016) |
2016 |
| Name | Position | Year Started | Year Ended |
|---|---|---|---|
Managing Director, Chief Executive
|
2009 | 2016 |
| Date | Company | Transaction Type | Total Value | |
|---|---|---|---|---|
| Anteo Diagnostics | Entitlement offer | $3.65m | >> |
